Spring direct naar de hoofdnavigatie of de inhoud

Marthe Lindenbergh

Patent attorney

‘An adequate IP strategy protects innovation and creates new chances’
Marthe Lindenbergh

Marthe Lindenbergh

  • Life Sciences
  • Trainee Patent Attorney

Marthe Lindenbergh obtained a Bachelor’s and Master’s degree in Biomedical Sciences at Utrecht University. During the Master-phase, she did research internships in the UMC Utrecht and at the University of California, San Francisco. Having specialized in Infection and Immunity, she continued her studies with a PhD track at Utrecht University and the Wilhelmina Children’s Hospital, where she studied the immune-modulatory functions of immune-cell-derived extracellular vesicles.

Continue reading

Working experience

  • Trainee Patent Attorney V.O. (2019-present)
  • PhD University of Utrecht (2014-2018)

Education

  • MSc Infection and Immunity, University ofUtrecht (2014)
  • BSc Biomedical Sciences , University of Utrecht (2012)

Publications

  • M. Mues, L. Karra, D. Romero-Moya, A. Wandler, M. J. Hangauer, O. Ksionda, Y. Thus, M.F.S. Lindenbergh, K. Shannon, M. T. McManus, J. P. Roose. “High-complexity shRNA libraries and PI3 kinase inhibition in cancer: high-fidelity synthetic lethality predictions”. Cell Reports 2019
  • M.F.S. Lindenbergh, D.G.J. Koerhuis, E.G.F. Borg, E.M. van ’t Veld, T.A.P. Driedonks, R. Wubbolts, W. Stoorvogel, M. Boes. “Bystander T-cells support clonal T-cell activation by controlling the release of dendritic cell-derived immune-stimulatory extracellular vesicles”. Front. Imm. 2019
  • M.F.S. Lindenbergh, W. Stoorvogel. “Antigen presentation by extracellular vesicles from professional antigen-presenting cells”.  Annu. Rev. Immunol. 2018
  • A.M. Gram, T. Oosenbrug, M.F.S. Lindenbergh, C. Büll, A. Comvalius, K.J.I. Dickson, J. Wiegant, H. Vrolijk, R.J. Lebbink, R. Wolterbeek, G.J. Adema, M. Griffioen, M.H.M. Heemskerk, D.C. Tscharke, L. M. Hutt-Fletcher, E.J.H.J. Wiertz, R.C. Hoeben, M.E. Ressing. “The Epstein-Barr virus glycoprotein gp150 forms an immune-evasive glycan shield at the surface of infected cells”. PLoS Path. 2016
  • M. van Gent, A.M. Gram, I.G.J. Boer, R.J. Geerdink, M.F.S. Lindenbergh, R.J. Lebbink, E.J. Wiertz, M.E. Ressing. “Silencing the shutoff protein of Epstein-Barr virus in productively infected B cells points to (innate) targets for immune evasion”.  J. Gen. Virol. 2015.

Languages

  • Dutch
  • English

Also see these experts

Frits Michiels

Frits Michiels

  • European Patent Attorney
  • Dutch Patent Attorney
  • Senior Associate
Jetze Beeksma

Jetze Beeksma

  • European Patent Attorney
  • Dutch Patent Attorney
  • Associate
More experts

News

Knowledge sharing as keyword for optimal service provision

Sharing knowledge is not only the basic principle of the patent system – publishing the invention in exchange for the right to deter others from using it – but has also become an increasingly important driver of IP service provision.Continue reading

New Chairman of V.O.

As of 1 September, Herman Witmans will be the new Chairman of V.O. He is succeeding Cees Jansen. Cees has worked there for 26 years, of which more than 12 years as Chairman. He will remain associated with the organization as an advisor.Continue reading

The best-known medicine in the world: Aspirin

At the end of the 19th century, a young researcher from Bayer made one the most significant discoveries ever – the painkiller Aspirin. It was valuable for his employer, and also for his father who suffered from rheumatism. It led to a worldwide success!Continue reading

Events

European Patent Seminar

Hotel Excelsior München, Schützenstraße, Munich, Germany

Know the latest ins-and-outs concerning examination, opposition and appeal proceedings before the EPO. Be updated on the unitary patent and the unified patent court. Continue reading

Improve your practical knowledge at the IP Academy 2019 – Basic

Winthontlaan 6, 3526 KV Utrecht, Utrecht, Netherlands

Follow the annual course on patents, trademarks and designs. For innovative entrepreneurs who wish to improve their intellectual property (IP) know-how, V.O. Patents & Trademarks organizes a basic course on IP on Thursday 26 September. Continue reading

IPBC Asia 2019

Palace Hotel Tokyo, 1 Chome-1-1 Marunouchi, Chiyoda City, Tokyo, Japan

Returning to Tokyo, IPBC Asia 2019 is set to be the largest yet – building on the phenomenal success of the event since its launch in 2013. IPBC Asia is focused on chief IP officers, heads of intellectual property or their equivalents at major corporates from across Asia-Pacific; and their counterparts at major multinationals Continue reading